Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06506045 · ClinicalTrials.gov registry record
Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device
A clinical trial, sponsored by Rhaeos.
- Terminated
- Registry status
- 10
- Enrollment target
NCT06506045 is a clinical trial that was terminated before completion, run by Rhaeos. The registered enrollment target is 10 participants.
The verdict
NCT06506045 was terminated before completion, sponsored by Rhaeos.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of known non-functional and functional implanted shunts will assess the diagnostic non-inferiority of the second-generation device to the first-generation device.
Interventions
- DEVICE FlowSense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-07-27 |
| Est. Completion | 2024-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06506045
The ClinicalTrials.gov registry entry for NCT06506045 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FlowSense is the first listed.
NCT06506045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06506045 about?
NCT06506045 is a clinical study titled "Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device". This study compares the performance of two generations of non-invasive cerebrospinal fluid (CSF) shunt flow assessment devices. Measurements of known non-functional and functional implanted shunts will assess the diagnostic non-inferiority of the second-generation device to the first-generation devi...
What is the current status of trial NCT06506045?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2024-07-27. Estimated completion is 2024-07-27.
What interventions are being tested in trial NCT06506045?
The interventions under investigation include: FlowSense (DEVICE).
Who is sponsoring clinical trial NCT06506045?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.